{
  "Variants Include": [
    {
      "Gene": "PARK2",
      "variants": [
        {
          "HGVS": "NM_004324.3:c.1003A>G",
          "cDNA Change": {
            "transcript": "NM_004324.3",
            "ref": "A",
            "alt": "G",
            "position": "1003"
          },
          "Protein Change": {
            "ref": "S",
            "alt": "G",
            "position": "335"
          },
          "Description in input context": "c.1003A>G (p.S335G) in Parkin"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's Disease",
    "MONDO": "MONDO:0005039"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "HEK293 cells expressing wild-type and mutant (p.S335G) Parkin were used."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_004324.3:c.1003A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Protein ubiquitination activity was reduced by 40% in mutant Parkin-expressing cells."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type Parkin was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector transfection was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "3"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "2"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA with post-hoc Tukey's test was used."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Ubiquitination activity ≥ 75% of wild-type",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Ubiquitination activity < 50% of wild-type",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Immunoprecipitation",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "HEK293 cells overexpressing mutant Parkin (p.S335G) were used."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_004324.3:c.1003A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Mutant Parkin exhibited increased interaction with PINK1 compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Two biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each immunoprecipitation was repeated twice."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type Parkin was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "IgG control was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "t-test was used for comparison between groups."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Interaction signal intensity ≥ 2.5-fold over background",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Interaction signal intensity > 5-fold over background",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Cell Viability Assay",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "SH-SY5Y",
        "Description": "SH-SY5Y cells expressing wild-type and mutant (p.S335G) Parkin were used."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_004324.3:c.1003A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Mutant Parkin-expressing cells showed a 30% increase in apoptosis compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Four independent biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each viability measurement was repeated in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type Parkin was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Vehicle-treated cells were used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "4"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "3"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Two-way ANOVA with Bonferroni correction was used."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Cell viability ≥ 85% of wild-type",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Cell viability < 60% of wild-type",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}